{reportSlug=global-metastatic-uveal-melanoma-thereapeutics-market, reportId=60283, mktKeyword=Metastatic Uveal Melanoma Thereapeutics, cagr=0.00, publishDate=Jan 2022, priceOption2=6800, reportTitle=Metastatic Uveal Melanoma Thereapeutics Comprehensive Study by Type (Sunitinib Malate, Vincristine Sulfate Liposomal, LY-2801653, Sotrastaurin Acetate, Others), Application (Hospital, Clinic, Others), Diagnostic Tests (Ultrasonography, High-Resolution Ultrasound Biomicroscopy, Indocyanine Green Angiography, Fluorescein Angiography, Oclular Coherence Tomography), Stages (Early-Stage, Mid-Stage, Late Stage), Treatment Type (External Beam Proton Therapy, Transpupillary Thermotherapy, Surgical) Players and Region - Global Market Outlook to 2026, baseYr=2021, totalTableFig=160, priceOption1=3750, forecastYr=2027, noOfPages=223, reportKey=59960, breadcrum=Global Metastatic Uveal Melanoma Thereapeutics}
We do not share your information with anyone. However, we may send you
emails based on your report interest from time to time. You may contact
us at any time to opt-out.
Select User Access Type
Key Highlights of Report
Jan 2022
223 Pages
93 Tables
Base Year: 2021Coverage: 15+ Companies; 18
Countries